R&D facility at Creative Biolabs is fully equipped with modern laboratory spaces. The general laboratory space is divided into dedicated spaces for every work in immunology. Our scientific expertise provides highly customized solutions to meet every specific demand in cancer cell engineering for self-destruction purposes.
A comprehensive range of leukemia cells (including BV173, Kasumi-1Jurkat, and HL-60) can be engineered using genetic methods to turn leukemia cells against themselves.
A wild range of pancreatic cancer cells, including but not limited to PANC-1, HupT3, AsPC-1, CFPAC-1, PSN-1, and AR42J, are available to be engineered for cancer cell self-destruction purposes.
Colorectal cancer cells, such as cACO2, COLO205, LOVO, T84, and HCT116, can be engineered to turn Colorectal cancer cells against themselves.
Creative Biolabs is proficient at engineering prostate cancer cells (including DU-145, PC-3, LNCaP, and 22Rv1) to turn prostate cancer cells against themselves.
Scientists at Creative Biolabs lend their expertise and assist our clients to inspire the lymphangiogenic potentiation of immunotherapy to turn liver cancer cells (including HepG2, HuH-7, and MHCC97L) against themselves.
By applying our staff's experience and a proven quality system, Creative Biolabs continues to serve our clients with professionalism and expertise in breast cancer cell (including MCF7, MDA-MB-468, and HCC1937) engineering service.
Our years of experience, deep resources, and flexible service options can help deliver fast, reliable support for lung cancer cell (including A549, H358, CL1, and SW900) engineering service.
Creative Biolabs has built a team of experienced scientists with facilities designed specifically to meet every challenging requirement in gastric cancer cell (BGC-823, GES-1, AGS, NCI-N87, MKN, and SNU-216) engineering.
Our comprehensive portfolio provides reliable support to help our clients' projects regarding ovarian cancer cells (including A2780, OVCAR-3, CAOV3, SK-OV-3, and IGROV1) engineering for self-destruction purposes.
By leveraging the wealth of experience to inspire the lymphangiogenic potentiation of immunotherapy to turn cancer cells against themselves, we are pleased to provide melanoma cell engineering for self-destruction purposes.
Our technologies aim to facilitate the development of a new immunotherapy for neuroblastoma. Multiple genetic methods for cell line engineering, including retrovirus, lentivirus, adenovirus, adeno-associated virus, and CRISPR-based methods are involved.
Research scientists at Creative Biolabs are experts in cancer cell engineering and will assist clients based on their requirements. We provide efficiencies with shorter timelines to accelerate our clients' cancer immunotherapy development projects.
For more detailed information, please feel free to contact us or directly send us an inquiry.
Reference
For Research Use Only | Not For Clinical Use
Download our brochure